UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases

World journal of gastroenterology : WJG, 2014-11, Vol.20 (42), p.15787-15796

2014

Link zum Volltext

Verfügbarkeit prüfen

S1059 The Efficacy of Induction Treatment With Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 QUASAR Induction Study Results at Week 12 by Prior Advanced Therapy History

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S806-S807

2023

Link zum Volltext

Verfügbarkeit prüfen

Vitamin D Therapy in Inflammatory Bowel Diseases: Who, in What Form, and How Much?

Journal of Crohn's and colitis, 2015-02, Vol.9 (2), p.198-209

2015

Link zum Volltext

Verfügbarkeit prüfen

Seasonal changes of circulating 25-hydroxyvitamin D correlate with the lower gut microbiome composition in inflammatory bowel disease patients

Scientific reports, 2020-04, Vol.10 (1), p.6024-6024, Article 6024

2020

Link zum Volltext

Verfügbarkeit prüfen

Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study

World journal of gastroenterology : WJG, 2017-06, Vol.23 (22), p.4102-4111

2017

Link zum Volltext

Verfügbarkeit prüfen

Biological therapy in inflammatory bowel diseases:Access in Central and Eastern Europe

World journal of gastroenterology : WJG, 2015-02, Vol.21 (6), p.1728-1737

2015

Link zum Volltext

Verfügbarkeit prüfen

Nuclear and Mitochondrial Circulating Cell-Free DNA Is Increased in Patients With Inflammatory Bowel Disease in Clinical Remission

Frontiers in medicine, 2020-12, Vol.7, p.593316-593316

2020

Link zum Volltext

Verfügbarkeit prüfen

The Value of Myenteric Plexitis to Predict Early Postoperative Crohn’s Disease Recurrence

Gastroenterology (New York, N.Y. 1943), 2006-05, Vol.130 (6), p.1595-1606

2006

Link zum Volltext

Verfügbarkeit prüfen

Biosimilars in the therapy of inflammatory bowel diseases

European journal of gastroenterology & hepatology, 2014-06, Vol.26 (6), p.581-587

2014

Link zum Volltext

Verfügbarkeit prüfen

The relationship between selected VDR gene polymorphisms and susceptibility to inflammatory bowel disease in Slovak population

Biológia, 2019-05, Vol.74 (5), p.573-581

2019

Link zum Volltext

Verfügbarkeit prüfen

Ovarian Reserve Assessed by the Anti-Mullerian Hormone and Reproductive Health Parameters in Women With Crohn’S Disease, a Case-Control Study

Physiological research, 2021-11, Vol.70 (Suppl 1), p.S69-S78

2021

Link zum Volltext

Verfügbarkeit prüfen

Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors

Scandinavian journal of gastroenterology, 2012-02, Vol.47 (2), p.197-203

2012

Link zum Volltext

Verfügbarkeit prüfen

Colorectal cancer screening in patients with ulcerative and crohnʼs colitis with use of colonoscopy, chromoendoscopy and confocal endomicroscopy

European journal of gastroenterology & hepatology, 2011-08, Vol.23 (8), p.680-689

2011

Link zum Volltext

Verfügbarkeit prüfen

A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease

Clinical gastroenterology and hepatology, 2014-09, Vol.12 (9), p.1485-1493.e2

2014

Link zum Volltext

Verfügbarkeit prüfen

Real-world observational cohort study of treatment patterns and safety outcomes of infliximab biosimilar CT-P13 for the treatment of inflammatory bowel disease (CONNECT-IBD)

Expert opinion on biological therapy, 2023-08, Vol.ahead-of-print (ahead-of-print), p.1-10

2023

Link zum Volltext

Verfügbarkeit prüfen

Predictive value of infliximab trough levels in maintenance therapy for 5-year sustained clinical remission in patients with inflammatory bowel disease

Bratislavské lékarské listy, 2023, Vol.124 (7), p.485-492

2023

Link zum Volltext

Verfügbarkeit prüfen

Decrease of trabecular bone score reflects severity of Crohn’s disease: results of a case–control study

European journal of gastroenterology & hepatology, 2018-01, Vol.30 (1), p.101-106

2018

Link zum Volltext

Verfügbarkeit prüfen

Delayed hypersensitivity reaction after initial dose of infliximab: a case report

European journal of gastroenterology & hepatology, 2014-04, Vol.26 (4), p.485-487

2014

Link zum Volltext

Verfügbarkeit prüfen

Access to biologicals in Crohn’s disease in ten European countries

World journal of gastroenterology : WJG, 2017-09, Vol.23 (34), p.6294-6305

2017

Link zum Volltext

Verfügbarkeit prüfen

Su1155 Effectiveness of the Screening for Latent Tuberculosis in Inflammatory Bowel Disease Patients With Previous BCG Vaccination

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-413-S-414

2013

Link zum Volltext

Verfügbarkeit prüfen

Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials

The lancet. Gastroenterology & hepatology, 2022-01, Vol.7 (1), p.17-27

2022

Link zum Volltext

Verfügbarkeit prüfen

Association of Organic Cation Transporter Risk Haplotype With Perianal Penetrating Crohn’s Disease but Not With Susceptibility to IBD

Gastroenterology (New York, N.Y. 1943), 2005-12, Vol.129 (6), p.1845-1853

2005

Link zum Volltext

Verfügbarkeit prüfen

Smoking, breastfeeding, physical inactivity, contact with animals, and size of the family influence the risk of inflammatory bowel disease: A Slovak case–control study

United European gastroenterology journal, 2013-04, Vol.1 (2), p.109-119

2013

Link zum Volltext

Verfügbarkeit prüfen

Predictive model for the outcome of infliximab therapy in Crohn's disease based on apoptotic pharmacogenetic index and clinical predictors

Inflammatory bowel diseases, 2007-04, Vol.13 (4), p.372-379

2007

Link zum Volltext

Verfügbarkeit prüfen

Mo1380 Smoking, Breastfeeding, Physical Inactivity, Contact With Animals, and Size of the Family Influence the Risk of Inflammatory Bowel Diseases in a Slovak Case-Control Study

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-651-S-651

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(50)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(25)
Science & Technology
(22)
Life Sciences & Biomedicine
(21)
Female
(16)
Male
(16)
Gastroenterology & Hepatology
(15)
Crohn's Disease
(14)
Middle Aged
(13)
Ulcerative Colitis
(12)
Adult
(11)
Inflammatory Bowel Disease
(9)
Infliximab
(8)
Aged
(7)
Crohn Disease - Drug Therapy
(7)
Young Adult
(7)
Crohn’s Disease
(6)
Gastroenterology And Hepatology
(6)
Severity Of Illness Index
(6)
Inflammatory Bowel Diseases
(5)
Inflammatory Bowel Diseases - Drug Therapy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases

S1059 The Efficacy of Induction Treatment With Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 QUASAR Induction Study Results at Week 12 by Prior Advanced Therapy History

Vitamin D Therapy in Inflammatory Bowel Diseases: Who, in What Form, and How Much?

Seasonal changes of circulating 25-hydroxyvitamin D correlate with the lower gut microbiome composition in inflammatory bowel disease patients

Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study

Biological therapy in inflammatory bowel diseases:Access in Central and Eastern Europe

Nuclear and Mitochondrial Circulating Cell-Free DNA Is Increased in Patients With Inflammatory Bowel Disease in Clinical Remission

The Value of Myenteric Plexitis to Predict Early Postoperative Crohn’s Disease Recurrence

Biosimilars in the therapy of inflammatory bowel diseases

The relationship between selected VDR gene polymorphisms and susceptibility to inflammatory bowel disease in Slovak population

Ovarian Reserve Assessed by the Anti-Mullerian Hormone and Reproductive Health Parameters in Women With Crohn’S Disease, a Case-Control Study

Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors

Colorectal cancer screening in patients with ulcerative and crohnʼs colitis with use of colonoscopy, chromoendoscopy and confocal endomicroscopy

A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease

Real-world observational cohort study of treatment patterns and safety outcomes of infliximab biosimilar CT-P13 for the treatment of inflammatory bowel disease (CONNECT-IBD)

Predictive value of infliximab trough levels in maintenance therapy for 5-year sustained clinical remission in patients with inflammatory bowel disease

Decrease of trabecular bone score reflects severity of Crohn’s disease: results of a case–control study

Delayed hypersensitivity reaction after initial dose of infliximab: a case report

Access to biologicals in Crohn’s disease in ten European countries

Su1155 Effectiveness of the Screening for Latent Tuberculosis in Inflammatory Bowel Disease Patients With Previous BCG Vaccination

Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials

Association of Organic Cation Transporter Risk Haplotype With Perianal Penetrating Crohn’s Disease but Not With Susceptibility to IBD

Smoking, breastfeeding, physical inactivity, contact with animals, and size of the family influence the risk of inflammatory bowel disease: A Slovak case–control study

Predictive model for the outcome of infliximab therapy in Crohn's disease based on apoptotic pharmacogenetic index and clinical predictors

Mo1380 Smoking, Breastfeeding, Physical Inactivity, Contact With Animals, and Size of the Family Influence the Risk of Inflammatory Bowel Diseases in a Slovak Case-Control Study

Suchergebnisse filtern